Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in New Jersey, for $11.75 billion. Sun Pharma acquisitions are aimed at expanding global biosimilars and established brands by adding Organon’s portfolio of more than 70 products, supported by six manufacturing sites across the EU and emerging markets. Organon acquisition also strengthens Sun Pharma’s position in women’s health while supporting a strategic acquisition of a cash-generating platform. The merger acquisition is an all-cash strategic acquisition by an India-based buyer, with the healthcare M&A expected to close in early next year and priced at $14 per Organon share.